Synergistic enhancement of cognitive ability
AssigneeNeurologic, Inc.
InventorsDaniel L. Alkon, Mlao-Kun Sun
Life of this patent
Estimating the term…
Abstract
The present invention relates to the combination of a methylxanthine and a carbonic anhydrase activator to provide synergistic effects. The invention further relates to the improved/enhanced cognitive ability of individuals, particularly those suffering from various disorders, such as Alzheimer's Disease, stroke, hypoxia, general dementia, ADHD, mental retardation, and “sun down” syndrome.
Claims22
A method for enhancing cognitive ability comprising administering to a subject a combination of a methylxanthine and a carbonic anhydrase activator in an amount effective to enhance cognitive ability of said subject in a pharmaceutically suitable carrier.
A method for treating a subject with Alzheimer's Disease comprising administering to said subject a pharmaceutically effective amount of a combination of a methylxanthine and a carbonic anhydrase inhibitor.
A method for treating a subject with Alzheimer's Disease comprising administering to said subject a pharmaceutically effective amount of a combination of theophylline and phenylalanine.
A method for enhancing cognitive ability of a subject comprising administering to said subject a pharmaceutically effective amount of a combination of a methylxanthine and a carbonic anhydrase activator.
A method for enhancing cognitive ability of a subject comprising administering to said subject a pharmaceutically effective amount of a combination of theophylline and phenylalanine.
A method for treating hypoxia comprising administering to a subject a pharmaceutically effective amount of a combination of a methylxanthine and a carbonic anhydrase activator.
A method for treating hypoxia comprising administering to a subject a pharmaceutically effective amount of a combination of theophylline and phenylalanine.
A method for providing a neuroprotective effect for cells which suffer from a hypoxic event comprising administering to a subject in need of such effect a pharmaceutically effective amount of a combination of a methylxanthine and a carbonic anhydrase activator.
A method for providing a neuroprotective effect for cells which suffer from a hypoxic event comprising administering to a subject in need of such effect a pharmaceutically effective amount of a combination of theophylline and phenylalanine.
A composition comprising a combination of a methylxanthine and a carbonic anhydrase activator in an amount effective to enhance cognitive ability, and a pharmaceutically effective carrier.
Dependencies are inferred from the claim text.